Highlight Therapeutics
PrivateLast Round
Growth Equity
Sep 16, 2025
Total Funding Raised
$44.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Highlight Therapeutics is a biopharmaceutical company that develops RNA-based immuno-oncology therapies designed to stimulate the immune system and enhance anti-tumor responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Highlight Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Highlight Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 16, 2025 | ||||
| Series B | Feb 5, 2021 |
Key People
Founding team and executive leadership
Highlight Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advent Life Sciences | Series B |
| GED Capital | Growth Equity |
| Buenavista Equity Partners | Growth Equity |
| Center for Technological Development and Innovation | Series B |
| Columbus Venture Partners | Growth Equity, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
$18M raised in a VC Round.
- Sep 4, 2025
Abel Riera appointed as new Chief Business Officer.
Highlight Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Highlight Therapeutics's valuation, stock price, and market status.